Item 7.01 Regulation FD Disclosure.
On
In accordance with General Instruction B.2. of Form 8-K, the information in this Item 7.01 and Exhibit 99.1 hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference in any of the Company's filings under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof, regardless of any incorporation language in such a filing, except as expressly set forth by specific reference in such a filing.
Item 8.01 Other Events.
On
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits Exhibit Number Exhibit Description 99.1 Company Presentation. 99.2 Press Release datedJanuary 19, 2021 . 104 The cover page fromAclaris Therapeutics, Inc.'s Form 8-K filed onJanuary 19, 2021 , formatted in Inline XBRL. 2
© Edgar Online, source